Safety and pharmacokinetics of dolutegravir in HIV-positive pregnant women: a systematic review

• Main Authors: An.drew Hill (Author), Polly Clayden (Author), Claire Thorne (Author), Rachel Christie (Author), Rebecca Zash (Author)
• Format: Book
• Published: Elsevier, 2018-04-01T00:00:00Z.
• Subjects: article
• Online Access: Connect to this object online.

Background: The integrase strand transfer inhibitor dolutegravir (DTG) is being introduced into low- and middle-income countries (LMICs) as an alternative to first-line treatment with non-nucleoside reverse transcriptase inhibitors. However, DTG is not yet widely recommended for use in pregnant wome...